Norinchukin Bank’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.02M | Buy |
17,138
+9,420
| +122% | +$5.28M | 0.09% | 121 |
|
|
2026
Q1 | $4.34M | Buy |
7,718
+274
| +4% | +$176K | 0.05% | 203 |
|
|
2025
Q4 | $5.04M | Buy |
7,444
+38
| +0.5% | +$25.9K | 0.06% | 174 |
|
|
2025
Q3 | $4.73M | Sell |
7,406
-246
| -3% | -$149K | 0.06% | 169 |
|
|
2025
Q2 | $4.1M | Buy |
7,652
+203
| +3% | +$97.1K | 0.06% | 187 |
|
|
2025
Q1 | $3.13M | Buy |
7,449
+1,855
| +33% | +$805K | 0.06% | 199 |
|
|
2024
Q4 | $2.31M | Buy |
5,594
+460
| +9% | +$202K | 0.05% | 213 |
|
|
2024
Q3 | $2.59M | Buy |
5,134
+477
| +10% | +$232K | 0.06% | 187 |
|
|
2024
Q2 | $2.27M | Sell |
4,657
-459
| -9% | -$230K | 0.06% | 171 |
|
|
2024
Q1 | $2.76M | Sell |
5,116
-601
| -11% | -$328K | 0.08% | 146 |
|
|
2023
Q4 | $3.17M | Sell |
5,717
-17,511
| -75% | -$8.22M | 0.07% | 134 |
|
|
2023
Q3 | $10.2M | Sell |
23,228
-1,929
| -8% | -$962K | 0.24% | 60 |
|
|
2023
Q2 | $12.6M | Buy |
25,157
+3,712
| +17% | +$1.78M | 0.21% | 83 |
|
|
2023
Q1 | $10.7M | Buy |
21,445
+1,158
| +6% | +$554K | 0.21% | 74 |
|
|
2022
Q4 | $8.28M | Sell |
20,287
-5,581
| -22% | -$2.17M | 0.18% | 86 |
|
|
2022
Q3 | $8.43M | Buy |
25,868
+608
| +2% | +$223K | 0.17% | 89 |
|
|
2022
Q2 | $8.86M | Buy |
25,260
+13,835
| +121% | +$5.64M | 0.17% | 83 |
|
|
2022
Q1 | $6.25M | Buy |
11,425
+3,453
| +43% | +$1.82M | 0.08% | 140 |
|
|
2021
Q4 | $5.25M | Sell |
7,972
-536
| -6% | -$336K | 0.07% | 153 |
|
|
2021
Q3 | $5.29M | Buy |
8,508
+460
| +6% | +$309K | 0.07% | 143 |
|
|
2021
Q2 | $5.08M | Buy |
8,048
+112
| +1% | +$61.8K | 0.07% | 140 |
|
|
2021
Q1 | $3.88M | Buy |
7,936
+376
| +5% | +$188K | 0.05% | 163 |
|
|
2020
Q4 | $3.78M | Sell |
7,560
-8
| -0.1% | -$3.58K | 0.05% | 150 |
|
|
2020
Q3 | $2.98M | Buy |
7,568
+208
| +3% | +$76.9K | 0.05% | 164 |
|
|
2020
Q2 | $2.43M | Sell |
7,360
-109
| -1% | -$31.6K | 0.04% | 179 |
|
|
2020
Q1 | $1.81M | Sell |
7,469
-4,165
| -36% | -$1.09M | 0.04% | 196 |
|
|
2019
Q4 | $3.04M | Sell |
11,634
-1,058
| -8% | -$279K | 0.04% | 251 |
|
|
2019
Q3 | $3.45M | Buy |
12,692
+324
| +3% | +$90.2K | 0.05% | 231 |
|
|
2019
Q2 | $3.4M | Sell |
12,368
-4,179
| -25% | -$1.03M | 0.05% | 224 |
|
|
2019
Q1 | $3.7M | Buy |
16,547
+480
| +3% | +$99.1K | 0.05% | 253 |
|
|
2018
Q4 | $2.99M | Buy |
16,067
+4,940
| +44% | +$1.01M | 0.04% | 258 |
|
|
2018
Q3 | $2.78M | Buy |
11,127
+1,291
| +13% | +$313K | 0.04% | 246 |
|
|
2018
Q2 | $2.14M | Buy |
9,836
+1,853
| +23% | +$382K | 0.03% | 263 |
|
|
2018
Q1 | $1.53M | Sell |
7,983
-2,788
| -26% | -$515K | 0.03% | 303 |
|
|
2017
Q4 | $1.68M | Buy |
10,771
+4,276
| +66% | +$673K | 0.03% | 282 |
|
|
2017
Q3 | $1.01M | Buy |
6,495
+379
| +6% | +$59.9K | 0.02% | 368 |
|
|
2017
Q2 | $987K | Buy |
6,116
+396
| +7% | +$64.3K | 0.02% | 361 |
|
|
2017
Q1 | $884K | Buy |
+5,720
| New | +$788K | 0.02% | 372 |
|
Other funds holding IDXX
Norinchukin Bank's IDXX Position: Q2 2026 in Review
Norinchukin Bank increased its Idexx Laboratories (IDXX) stake by 122% in Q2 2026, buying an estimated $5.28M and bringing the position to 17,138 shares worth $9.02M. The position accounts for 0.09% of the portfolio, ranked #121.
Norinchukin Bank first reported a position in IDXX in Q1 2017 and has held it in 38 quarters since. The position peaked at $12.6M in Q2 2023. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Norinchukin Bank held 17,138 shares of Idexx Laboratories worth $9.02M as of Q2 2026.
- Norinchukin Bank bought 9,420 Idexx Laboratories shares in Q2 2026, an estimated $5.28M.
- Idexx Laboratories made up 0.09% of Norinchukin Bank's portfolio in Q2 2026, its #121 holding.
- Norinchukin Bank first reported a position in Idexx Laboratories in Q1 2017 and has held it in 38 quarters since.
- Norinchukin Bank's Idexx Laboratories position peaked at $12.6M in Q2 2023.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.